The figure shows how the hepatitis B virus (HBV) infection is restricted by two sites on the macaque liver cell receptor NTCP. (a) Cryo-electron microscopic structure of macaque NTCP (cyan)-bile acid ...

Hepatitis B virus (HBV) infects more than 250 million people worldwide and can lead to chronic liver disease and liver cancer. Current antiviral therapies suppress viral replication but do not ...

Cryo-electron microscopy reveals the structural basis for the restriction of hepatitis B virus (HBV) entry in macaques, enhancing our understanding of viral dynamics. A team of researchers from the ...

The human leucocyte antigen (HLA)-C and killer immunoglobin-like receptor (KIR) genotypes are associated with response to interferon-based therapy in patients with chronic hepatitis B virus (HBV) ...

In preclinical studies at Sunshine Lake Pharma Co. Ltd., researchers investigated the antiviral and immune-modulatory potential of HEC-191834, a novel and highly selective human Toll-like receptor 8 ...

Arbutus Biopharma Corporation announced promising data from a late-breaker poster presentation at the EASL Congress 2025, revealing that its treatment combining imdusiran, a RNAi therapeutic, with VTP ...

Please provide your email address to receive an email when new articles are posted on . The hepatitis B vaccine is safe and effective for preventing HBV infection in newborns. Universal HBV ...

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through ...